Literature DB >> 22078672

Moving toward precision medicine.

.   

Abstract

Mesh：

Year:  2011        PMID： 22078672     DOI： 10.1016/S0140-6736(11)61725-X

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  The MURDOCK Study: a long-term initiative for disease reclassification through advanced biomarker discovery and integration with electronic health records.

Authors:  Jessica D Tenenbaum; Victoria Christian; Melissa A Cornish; Rowena J Dolor; Ashley A Dunham; Geoffrey S Ginsburg; Virginia B Kraus; John G McHutchison; Meredith L Nahm; L Kristin Newby; Laura P Svetkey; Krishna Udayakumar; Robert M Califf
Journal:  Am J Transl Res       Date:  2012-07-23       Impact factor: 4.060

2.  From "Personalized" to "Precision" Medicine: The Ethical and Social Implications of Rhetorical Reform in Genomic Medicine.

Authors:  Eric Juengst; Michelle L McGowan; Jennifer R Fishman; Richard A Settersten
Journal:  Hastings Cent Rep       Date:  2016-09       Impact factor: 2.683

Review 3.  Toward precision medicine in neurological diseases.

Authors:  Lin Tan; Teng Jiang; Lan Tan; Jin-Tai Yu
Journal:  Ann Transl Med       Date:  2016-03

Review 4.  A roadmap for precision medicine in the epilepsies.

Authors: 
Journal:  Lancet Neurol       Date:  2015-09-20       Impact factor: 44.182

5.  A Novel Computerized Clinical Decision Support System for Treating Thrombolysis in Patients with Acute Ischemic Stroke.

Authors:  Ji Sung Lee; Chi Kyung Kim; Jihoon Kang; Jong-Moo Park; Tai Hwan Park; Kyung Bok Lee; Soo Joo Lee; Yong-Jin Cho; Jaehee Ko; Jinwook Seo; Hee-Joon Bae; Juneyoung Lee
Journal:  J Stroke       Date:  2015-05-29       Impact factor: 6.967

Review 6.  Personalized medicine in rheumatology: the paradigm of serum autoantibodies.

Authors:  Silvia Sirotti; Elena Generali; Angela Ceribelli; Natasa Isailovic; Maria De Santis; Carlo Selmi
Journal:  Auto Immun Highlights       Date:  2017-07-12

7.  High Dose Steroids as First-Line Treatment Increased the Risk of In-Hospital Infections in Patients With Anti-NMDAR Encephalitis.

Authors:  Jierui Wang; Jingfang Lin; Minjin Wang; Zirui Meng; Dong Zhou; Jinmei Li
Journal:  Front Immunol       Date:  2021-12-17       Impact factor: 7.561
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.